Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | X024650 | IM / RA |
No contraindications or precautions on screening prior to vaccination. Following administration of vaccine in seated position, client reported feeling lightheaded. Client placed in supine position. This nurse called health department nurse manager to the room. Client appeared to experience syncopal episode with muscle stiffening. Client s legs elevated. Client returned to consciousness within seconds. Vital signs monitored. Client declined emergency medical services contact. Client provided cool water and candy which were tolerated well. Client declined cool cloth or cool pack. Client alert and oriented to person, place, time, and situation. Client denied previous reactions to vaccines in the past. Continued to monitor client with stable vital signs in supine, sitting, and standing positions. Regional medical director notified. Client encouraged to follow up with personal medical provider. Client voiced understanding. Client encouraged to notify providers of reaction following receipt of vaccine prior to any future injections or procedures. Client voiced understanding. Client informed that per regional medical director client cannot receive any further doses of HPV vaccine from clinics. Client voiced understanding. Vital signs stable. Client ambulatory with steady gait without assistance. No symptoms present at time of discharge from clinic. Regional immunization program manager notified.
None per patient
ADHD
None per patient
None per patient on screening prior to vaccination